185 Aufrufe 185 0 Kommentare 0 Kommentare

    Just - Evotec Biologics Opens Cutting-Edge Biologics Facility - J.POD(R) Toulouse, France (EU)

    J.POD Toulouse, France (EU) brings disruptive, scalable continuous biologics manufacturing technology to the regionJust - Evotec Biologics' J.POD technology offers a paradigm shift in biomanufacturing with cost-effective and flexible clinical and …

    • J.POD Toulouse, France (EU) brings disruptive, scalable continuous biologics manufacturing technology to the region

    • Just - Evotec Biologics' J.POD technology offers a paradigm shift in biomanufacturing with cost-effective and flexible clinical and commercial supply solutions

    Anzeige 
    Handeln Sie Ihre Einschätzung zu Nasdaq Stock Market Inc!
    Short
    77,50€
    Basispreis
    1,48
    Ask
    × 13,49
    Hebel
    Zum Produkt
    Long
    67,63€
    Basispreis
    0,50
    Ask
    × 13,31
    Hebel
    Zum Produkt
    Präsentiert von

    Den Basisprospekt sowie die Endgültigen Bedingungen und die Basisinformationsblätter erhalten Sie bei Klick auf das Disclaimer Dokument. Beachten Sie auch die weiteren Hinweise zu dieser Werbung.

    HAMBURG, GERMANY and TOULOUSE, FRANCE / ACCESSWIRE / September 20, 2024 / Just - Evotec Biologics, the biologics segment of Evotec SE (Frankfurt Stock Exchange:EVT)(MDAX/TecDAX, ISIN: DE0005664809)(NASDAQ:EVO), today celebrated the Grand Opening of its J.POD biologics development and manufacturing facility located on Evotec's Campus Curie in Toulouse, France. The J.POD facility in Toulouse, the second of its kind and the first in Europe, utilizes Just - Evotec Biologics' adaptable J.POD technology to provide essential clinical and commercial biologics manufacturing capacity.

    During a ceremony on Campus Curie, Pierre-André Durand, Prefect of Haute-Garonne and Occitanie, Jean-Luc Moudenc, President of Toulouse Métropole and Mayor of Toulouse as well as Jalil Benabdillah, Vice-President, Economy, Employment, Innovation and Reindustrialisation of the Occitanie region, joined the Management of Evotec and Just - Evotec Biologics, to inaugurate the new facility.

    Dr Christian Wojczewski, Chief Executive Officer of Evotec, commented: "J.POD is a bioprocessing facility by Just - Evotec Biologics that uses advanced technology to fulfill its mission of making biotherapeutics more accessible worldwide. The opening of J.POD Toulouse, France (EU), our first J.POD on European ground, represents a proud moment and a significant milestone for our Company. We are very thankful for the support from the French government, the Occitanie Region, Bpifrance, the Haute-Garonne prefecture, and Toulouse Métropole for helping us achieve this milestone at our Campus Curie in Toulouse. We also want to give special credit to our dedicated team, whose hard work and commitment made this possible."

    J.POD Toulouse, France (EU) brings much-needed biologics manufacturing capacity to Europe. Biologics offer a potent therapeutic solution applicable to various indications. However, conventional fed-batch manufacturing poses significant hurdles, particularly during the transition from clinical to commercial scale. The J.POD technology, with its modular continuous manufacturing approach, enables highly intensified cGMP production of biologics at flexible quantities, effectively mitigating scale-up risks and reducing manufacturing costs.

    Seite 1 von 4
    Der Analyst erwartet ein Kursziel von 5,60, was eine Steigerung von +5,35% zum aktuellen Kurs entspricht. Mit diesen Produkten können Sie die Kurserwartungen des Analysten übertreffen.
    Übernehmen
    Für Ihre Einstellungen haben wir keine weiteren passenden Produkte gefunden.
    Bitte verändern Sie Kursziel, Zeitraum oder Emittent.
    Alternativ können Sie auch unsere Derivate-Suchen verwenden
    Knock-Out-Suche | Optionsschein-Suche | Zertifikate-Suche
    WerbungDisclaimer


    Diskutieren Sie über die enthaltenen Werte


    Accesswire
    0 Follower
    Autor folgen
    Mehr anzeigen
    We’re a newswire service standout and fast becoming an industry disruptor. We provide regional, national and global news to thousands of clients around the world. We’re also leading the way in social engagement, targeting and analytics.
    Mehr anzeigen

    Verfasst von Accesswire
    Just - Evotec Biologics Opens Cutting-Edge Biologics Facility - J.POD(R) Toulouse, France (EU) J.POD Toulouse, France (EU) brings disruptive, scalable continuous biologics manufacturing technology to the regionJust - Evotec Biologics' J.POD technology offers a paradigm shift in biomanufacturing with cost-effective and flexible clinical and …